% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • sy3dney sy3dney Feb 24, 2006 11:30 AM Flag

    OK - the DNA website Feb update


    HER2 has been added to pI.

    But continue to scroll down to Pre-IND.
    2 new compounds for oncology listed but are classified TBA (to be announced)

    Hey, we've got a chance that at least one of them involves IMGN.

    Just reading between the lines with the accumulation orders showing up daily now, and the recent DNA update. We've got ma and pa selling to somebody with a lot of money.

    Just trying to level the playing field here --


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • It's great to see traztusumab-DM1 on DNA website. Did you notice it is listed as Phase I already. That sounds like patient dosing is eminant. In M'itch's last presentation he said patient dosing was planned. He should know, the drug has to be ordered from IMGN.

      Many times over the last two years I've searched the DNA web site for DM1 and mertansine. They sure did manage to keep things buttoned up tight. Now the news is out, I'd like someone to tell Wall Street.

      Nice close today.

      Anyone want to bet that one or both those Pre-IND undisclosed new molecules on the DNA web site are congugates? My money says at least one is one of our babies.

      Good luck to all.

    • to see her2/dm1 listed was what we have been waiting for, for at least five years...

      then to see two other oncology molecules in the wings...course we don't know...for sure...but there are the licenses...and the patents...

      for dna to list the tba phase 1's is pretty near a certainty that they will show up...i would imagine, unlike immunogen's 'soon' mitch's defense, most of his predictions were based on other peoples agendas...

      thanks sydney...


7.64-0.34(-4.26%)Feb 5 4:00 PMEST